Actively Recruiting
Clinical Evaluation of Skin Microbiome an Over-The-Counter (OTC) Drug for Atopic Dermatitis
Led by Good Molecules, LLC · Updated on 2026-04-09
36
Participants Needed
1
Research Sites
12 weeks
Total Duration
On this page
Sponsors
G
Good Molecules, LLC
Lead Sponsor
S
Sequential Skin Inc.
Collaborating Sponsor
AI-Summary
What this Trial Is About
This is a research study. The over-the-counter (OTC) drug for atopic dermatitis being tested is not approved as a treatment for the participants' atopic dermatitis condition. In participating in this study, the investigators will analyze the participants' skin microbiome, measure skin hydration and barrier function, and assess clinical improvements to help us understand the potential impact of the investigational OTC drug on atopic dermatitis and skin microbiome balance.
CONDITIONS
Official Title
Clinical Evaluation of Skin Microbiome an Over-The-Counter (OTC) Drug for Atopic Dermatitis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Previously diagnosed Atopic Dermatitis with active, visible flare-ups at time of screening
- Dry or itchy skin patches on forearm, back of the hand, or posterior lower leg suitable for treatment assessment
- Evidence of inflammatory disease with documented diagnosis and current symptoms
- Stable skincare routine for 4 weeks prior to screening
- Willingness to avoid conflicting topical treatments during the study
- Experienced in applying topical treatments for atopic dermatitis
- Generally healthy aside from atopic dermatitis
- Provided free informed, written consent
- Willing to follow study protocol and procedures
You will not qualify if you...
- Pregnant or nursing women or planning pregnancy during the study
- Recent or current use of atopic dermatitis biological drugs within 4 weeks
- Recent use of systemic antibiotics, steroids, or immunomodulators within 4 weeks
- Active skin infections unrelated to atopic dermatitis
- Severe dermatologic conditions needing urgent medical care
- Use of treatments in previous weeks that could affect assessments
- Surgery under general anesthesia within the previous month
- Excessive sun or UV exposure within the previous month
- Scars or tattoos on forearms that interfere with assessments
- Participation in another clinical trial during this study or in past 30 days
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Sequential Skin
New York, New York, United States, 10013
Actively Recruiting
Research Team
P
Peca
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here